Profile
Sector:
Consumer DefensiveIndustry:
Household & Personal ProductsCountry:
United StatesIPO:
04 May 2023Website:
http://www.kenvue.comNext earnings report:
07 February 2025Last dividends:
13 November 2024Next dividends:
N/APrice
after hours | Sat, 23 Nov 2024 00:34:17 GMTAnalysts recommendations
Institutional Ownership
KVUE Latest News
Kenvue, Inc. (NYSE:KVUE) will hold its Q3 2024 Earnings Conference Call on November 7, 2024, at 8:00 AM ET. The call will feature company representatives including Sofya Tsinis, Thibaut Mongon, and Paul Ruh. Various analysts from major financial institutions will also participate in the discussion.
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) has released its financial results for the third quarter of the fiscal year, which ended on September 29, 2024.
Kenvue Inc (NYSE:KVUE), known for products like Listerine, Tylenol, Aveeno, and Band-Aid, announced sales that were a bit below expectations, but their earnings exceeded Wall Street's predictions. The company has gained more attention recently due to news that activist investor Starboard Value has invested in it and is considering potential changes.
Can making small changes really improve the appeal of this stock?
Ken Griffin's Citadel has recently acquired 18 million shares of a lesser-known consumer health company.
An activist investor is buying shares in Kenvue.
Starboard Value and Kenvue appear to be on the same page, and the situation could be favorable for creating value.
The growth of the consumer healthcare business might speed up now that an activist investor is taking part.
Starboard Value described Kenvue, a consumer products company, as a good deal and pointed out that the slow growth in its skin health and beauty division is why the stock has not been doing well.
Sylvia Jablonski, one of the co-founders of Defiance ETF, appears on 'Power Lunch' to talk about investment strategies for three different stocks.
What type of business is Kenvue?
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
What sector is Kenvue in?
Kenvue is in the Consumer Defensive sector
What industry is Kenvue in?
Kenvue is in the Household & Personal Products industry
What country is Kenvue from?
Kenvue is headquartered in United States
When did Kenvue go public?
Kenvue initial public offering (IPO) was on 04 May 2023
What is Kenvue website?
https://www.kenvue.com
Is Kenvue in the S&P 500?
Yes, Kenvue is included in the S&P 500 index
Is Kenvue in the NASDAQ 100?
No, Kenvue is not included in the NASDAQ 100 index
Is Kenvue in the Dow Jones?
No, Kenvue is not included in the Dow Jones index
When was Kenvue the previous earnings report?
No data
When does Kenvue earnings report?
The next expected earnings date for Kenvue is 07 February 2025